# QNB Corp.: financial statements, quarterly

QNBC · Nasdaq · CIK 750558 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/qnbc.md) · [Financials](/companies/qnbc/financials.md) · [Filings](/companies/qnbc/filings.md) · [Insiders](/companies/qnbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qnbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [8,284](/filings/0000950170-24-031946.md) | [9,065](/filings/0000950170-24-031946.md) | [9,401](/filings/0000950170-24-056531.md) | [9,753](/filings/0000950170-24-093462.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [494](/filings/0000950170-25-040857.md) | [302](/filings/0000950170-25-040857.md) | [663](/filings/0001193125-26-107482.md) | [544](/filings/0001193125-26-107482.md) | [961](/filings/0001193125-26-107482.md) | [743](/filings/0001193125-26-107482.md) | [624](/filings/0001193125-26-206302.md) | [1,005](/filings/0001193125-26-342264.md) | [922](/filings/0001193125-26-107482.md) | [1,289](/filings/0001193125-26-107482.md) | [707](/filings/0001193125-26-206302.md) | [817](/filings/0001193125-26-342264.md) |
| Net income | $k | [2,344](/filings/0000950170-25-040857.md) | [1,134](/filings/0000950170-25-040857.md) | [2,594](/filings/0001193125-26-107482.md) | [2,465](/filings/0001193125-26-107482.md) | [3,338](/filings/0001193125-26-107482.md) | [3,051](/filings/0001193125-26-107482.md) | [2,578](/filings/0001193125-26-206302.md) | [3,883](/filings/0001193125-26-342264.md) | [3,648](/filings/0001193125-26-107482.md) | [3,981](/filings/0001193125-26-107482.md) | [2,765](/filings/0001193125-26-206302.md) | [3,015](/filings/0001193125-26-342264.md) |
| Diluted EPS | $ per share | [0.65](/filings/0000950170-25-040857.md) | [0.31](/filings/0000950170-25-040857.md) | [0.71](/filings/0001193125-26-107482.md) | [0.67](/filings/0001193125-26-107482.md) | [0.91](/filings/0001193125-26-107482.md) | [0.83](/filings/0001193125-26-107482.md) | [0.69](/filings/0001193125-26-206302.md) | [1.04](/filings/0001193125-26-342264.md) | [0.98](/filings/0001193125-26-107482.md) | [1.06](/filings/0001193125-26-107482.md) | [0.73](/filings/0001193125-26-206302.md) | [0.60](/filings/0001193125-26-342264.md) |
| Basic EPS | $ per share | [0.65](/filings/0000950170-25-040857.md) | [0.31](/filings/0000950170-25-040857.md) | [0.71](/filings/0001193125-26-107482.md) | [0.67](/filings/0001193125-26-107482.md) | [0.91](/filings/0001193125-26-107482.md) | [0.83](/filings/0001193125-26-107482.md) | [0.70](/filings/0001193125-26-206302.md) | [1.05](/filings/0001193125-26-342264.md) | [0.98](/filings/0001193125-26-107482.md) | [1.07](/filings/0001193125-26-107482.md) | [0.74](/filings/0001193125-26-206302.md) | [0.61](/filings/0001193125-26-342264.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [55.1](/filings/0000950170-23-059799.md) | [62.7](/filings/0000950170-25-040857.md) | [51.0](/filings/0000950170-24-056531.md) | [76.9](/filings/0000950170-24-093462.md) | [104](/filings/0000950170-24-123155.md) | [50.7](/filings/0001193125-26-107482.md) | [81.6](/filings/0000950170-25-063961.md) | [66.5](/filings/0000950170-25-106928.md) | [66.3](/filings/0001193125-25-268178.md) | [50.3](/filings/0001193125-26-342264.md) | [56.6](/filings/0001193125-26-206302.md) | [79.3](/filings/0001193125-26-342264.md) |
| Total assets | $m | [1,684](/filings/0000950170-23-059799.md) | [1,706](/filings/0000950170-25-040857.md) | [1,716](/filings/0000950170-24-056531.md) | [1,761](/filings/0000950170-24-093462.md) | [1,842](/filings/0000950170-24-123155.md) | [1,871](/filings/0001193125-26-107482.md) | [1,896](/filings/0000950170-25-063961.md) | [1,885](/filings/0000950170-25-106928.md) | [1,903](/filings/0001193125-25-268178.md) | [1,906](/filings/0001193125-26-342264.md) | [1,923](/filings/0001193125-26-206302.md) | [2,399](/filings/0001193125-26-342264.md) |
| Total liabilities | $m | [1,610](/filings/0000950170-23-059799.md) | [1,615](/filings/0000950170-25-040857.md) | [1,622](/filings/0000950170-24-056531.md) | [1,665](/filings/0000950170-24-093462.md) | [1,736](/filings/0000950170-24-123155.md) | [1,768](/filings/0001193125-26-107482.md) | [1,788](/filings/0000950170-25-063961.md) | [1,772](/filings/0000950170-25-106928.md) | [1,782](/filings/0001193125-25-268178.md) | [1,776](/filings/0001193125-26-342264.md) | [1,792](/filings/0001193125-26-206302.md) | [2,215](/filings/0001193125-26-342264.md) |
| Long-term debt | $m | [20.0](/filings/0000950170-23-059799.md) | [20.0](/filings/0000950170-25-040857.md) | [20.0](/filings/0000950170-24-056531.md) | [30.0](/filings/0000950170-24-093462.md) | [30.0](/filings/0000950170-24-123155.md) | [30.0](/filings/0001193125-26-107482.md) | [30.0](/filings/0000950170-25-063961.md) | [0.0](/filings/0000950170-25-106928.md) | [0.0](/filings/0001193125-25-268178.md) | [0.0](/filings/0001193125-26-107482.md) | not reported | not reported |
| Short-term borrowings | $m | [96.7](/filings/0000950170-23-059799.md) | [94.1](/filings/0000950170-25-040857.md) | [55.1](/filings/0000950170-24-056531.md) | [49.1](/filings/0000950170-24-093462.md) | [22.9](/filings/0000950170-24-123155.md) | [53.8](/filings/0001193125-26-107482.md) | [43.3](/filings/0000950170-25-063961.md) | [67.5](/filings/0000950170-25-106928.md) | [48.7](/filings/0001193125-25-268178.md) | [80.6](/filings/0001193125-26-342264.md) | [86.8](/filings/0001193125-26-206302.md) | [75.4](/filings/0001193125-26-342264.md) |
| Shareholders' equity | $m | [74.1](/filings/0000950170-24-123155.md) | [90.8](/filings/0001193125-26-107482.md) | [93.7](/filings/0000950170-25-106928.md) | [96.9](/filings/0001193125-25-268178.md) | [105](/filings/0001193125-25-268178.md) | [103](/filings/0001193125-26-342264.md) | [108](/filings/0001193125-26-342264.md) | [113](/filings/0001193125-26-342264.md) | [121](/filings/0001193125-25-268178.md) | [130](/filings/0001193125-26-342264.md) | [131](/filings/0001193125-26-342264.md) | [184](/filings/0001193125-26-342264.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,019 d](/filings/0000950170-24-123155.md) | [6,032 d](/filings/0001193125-26-107482.md) | [1,605](/filings/0000950170-25-063961.md) | [4,047 d](/filings/0000950170-25-106928.md) | [4,048 d](/filings/0001193125-25-268178.md) | [6,517 d](/filings/0001193125-26-107482.md) | [(987)](/filings/0001193125-26-206302.md) | [5,731 d](/filings/0001193125-26-342264.md) | [3,591 d](/filings/0001193125-25-268178.md) | [8,287 d](/filings/0001193125-26-107482.md) | [(1,934)](/filings/0001193125-26-206302.md) | [6,884 d](/filings/0001193125-26-342264.md) |
| Dividends paid | $k | [1,173 d](/filings/0000950170-24-123155.md) | [1,186 d](/filings/0001193125-26-107482.md) | [1,198](/filings/0000950170-25-063961.md) | [1,198 d](/filings/0000950170-25-106928.md) | [1,201 d](/filings/0001193125-25-268178.md) | [1,201 d](/filings/0001193125-26-107482.md) | [1,238](/filings/0001193125-26-206302.md) | [1,251 d](/filings/0001193125-26-342264.md) | [1,253 d](/filings/0001193125-25-268178.md) | [1,258 d](/filings/0001193125-26-107482.md) | [1,309](/filings/0001193125-26-206302.md) | [1,769 d](/filings/0001193125-26-342264.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,568](/filings/0000950170-23-059799.md) | [3,588](/filings/0000950170-24-056531.md) | [3,599](/filings/0000950170-24-093462.md) | [3,613](/filings/0000950170-24-123155.md) | [3,655](/filings/0000950170-25-063961.md) | [3,666](/filings/0000950170-25-106928.md) | [3,683](/filings/0001193125-25-268178.md) | [3,713](/filings/0001193125-26-206302.md) | [3,725](/filings/0001193125-26-342264.md) | [3,736](/filings/0001193125-25-268178.md) | [3,776](/filings/0001193125-26-206302.md) | [5,002](/filings/0001193125-26-342264.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,979,570 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342264.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.